Pure Global

Intent Recognition for Prosthesis Control - Trial NCT05537792

Access comprehensive clinical trial information for NCT05537792 through Pure Global AI's free database. This phase not specified trial is sponsored by Georgia Institute of Technology and is currently Not yet recruiting. The study focuses on Amputation. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05537792
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05537792
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intent Recognition for Prosthesis Control
User-Independent Intent Recognition on a Powered Transfemoral Prosthesis

Study Focus

Amputation

Robotic Knee/Ankle Prosthesis

Interventional

device

Sponsor & Location

Georgia Institute of Technology

Atlanta, United States of America

Timeline & Enrollment

N/A

Jan 01, 2026

Jul 31, 2027

10 participants

Primary Outcome

Self-selected Walking Speed

Summary

This work will focus on new algorithms for powered prostheses and testing these in human
 subject tests. Individuals with above knee amputation will walk with a robotic prosthesis and
 ambulate over terrain that simulates community ambulation. The study will compare the
 performance of the advanced algorithm with their take-home device, as well as with the
 robotic system that does not use an advanced algorithm.

ICD-10 Classifications

Amputation of limb(s)
Traumatic amputation of both feet
Traumatic amputation of upper and lower limbs, any combination [any level]
Traumatic amputations involving other combinations of body regions
Traumatic amputation of lower leg

Data Source

ClinicalTrials.gov

NCT05537792

Device Trial